Beta‐hydroxy‐beta‐methylbutyrate supplementation and functional outcomes in multitrauma patients: A pilot randomized controlled trial

Abstract

A blinded, placebo-controlled, randomized clinical trial of daily enteral HMB supplementation for up to 28 days in hospital is feasible. Any effect of HMB supplementation to attenuate muscle wasting after traumatic injury remains uncertain.